Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Fabiane Milena Castro Araújo Pimenta"'
Autor:
Fabiane Milena Castro Araújo Pimenta, Anete Sevciovic Grumach, Aline Lury Aoki, Vivian Alves Costa, Sandra Mitie Ueda Palma, Rosemeire Navickas Constantino-Silva, Neusa Falbo Wandalsen, Ana Karolinne Burlamaqui Melo
Publikováno v:
The World Allergy Organization Journal
Background Hereditary Angioedema (HAE) is an autosomal dominant disorder resulting from a deficiency of C1 esterase inhibitor (C1-INH). It is a rare disease with clinical manifestations debilitating and potentially fatal. The aim of this study was to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26ca4b0aab9e9f957c237dcf3a61ad92
http://europepmc.org/articles/PMC4406688
http://europepmc.org/articles/PMC4406688
Autor:
Maria do Socorro Ferrao, Fabiane Milena Castro Araújo Pimenta, Vivian Alves Costa, Sandra Mitie Ueda Palma, Michael Kirschfink, V. G. Arruk, Alexandre Ely Campeas, Aline Lury Aoki, Anete Sevciovic Grumach, Rosemeire Navickas Constantino-Silva, Ana Karolinne Burlamaqui Melo, Myriam Raymundo
Publikováno v:
The World Allergy Organization Journal
Results A hundred and twenty nine patients (69M:60F) were included in the study. The age of the patients ranged from 2 months (m) up to 64 years old (mean= 96.2m; median=48m). The following serogroups were identified: type C, 36.4%; B, 20.2%; W135, 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a33a31fb4d7039c9da82b51e61599c44
http://europepmc.org/articles/PMC4406642
http://europepmc.org/articles/PMC4406642
Autor:
Ana Karolinne Burlamaqui Melo, Aline Lury Aoki, Rosemeire Navickas Constantino-Silva, Sandra Mitie Ueda Palma, Vivian Alves Costa, Fabiane Milena Castro Araújo Pimenta, Neusa Falbo Wandalsen, Anete Sevciovic Grumach
Publikováno v:
The World Allergy Organization Journal
Results Nineteen patients have been identified (2M:17F; 20-60 years old). The following therapies were oriented: combined contraceptive substitution for progestagen (10/19); treatment with progestagen (2/19); tranexamic acid (15/19): 1250mg (2), 1000
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a06ecf4bb6ce1361d45f7cab88c4b41
http://europepmc.org/articles/PMC4406706
http://europepmc.org/articles/PMC4406706